- Home
- SPKL vs GNFT Comparison
SPKL vs GNFT Comparison
Compare SPKL & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPKL
- GNFT
- Stock Information
- Founded
- SPKL 2021
- GNFT 1999
- Country
- SPKL United States
- GNFT France
- Employees
- SPKL N/A
- GNFT N/A
- Industry
- SPKL
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPKL
- GNFT Health Care
- Exchange
- SPKL Nasdaq
- GNFT Nasdaq
- Market Cap
- SPKL 176.5M
- GNFT 180.2M
- IPO Year
- SPKL 2023
- GNFT 2019
- Fundamental
- Price
- SPKL $10.76
- GNFT $3.67
- Analyst Decision
- SPKL
- GNFT Strong Buy
- Analyst Count
- SPKL 0
- GNFT 1
- Target Price
- SPKL N/A
- GNFT $13.00
- AVG Volume (30 Days)
- SPKL 3.8K
- GNFT 9.3K
- Earning Date
- SPKL 01-01-0001
- GNFT 04-24-2025
- Dividend Yield
- SPKL N/A
- GNFT N/A
- EPS Growth
- SPKL N/A
- GNFT N/A
- EPS
- SPKL 0.19
- GNFT 0.47
- Revenue
- SPKL N/A
- GNFT $86,225,222.00
- Revenue This Year
- SPKL N/A
- GNFT $145.20
- Revenue Next Year
- SPKL N/A
- GNFT N/A
- P/E Ratio
- SPKL $56.04
- GNFT $7.66
- Revenue Growth
- SPKL N/A
- GNFT 175.45
- 52 Week Low
- SPKL $10.26
- GNFT $3.11
- 52 Week High
- SPKL $11.95
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- SPKL 56.91
- GNFT 52.36
- Support Level
- SPKL $10.74
- GNFT $3.35
- Resistance Level
- SPKL $10.77
- GNFT $3.63
- Average True Range (ATR)
- SPKL 0.01
- GNFT 0.09
- MACD
- SPKL -0.00
- GNFT 0.01
- Stochastic Oscillator
- SPKL 50.00
- GNFT 88.89
About SPKL Spark I Acquisition Corp.
Spark I Acquisition Corp is a Blank check company.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.